OMEXA Formulary (India) Pvt Ltd, and OMEXA Biologics are a wholly owned subsidiary of Ayur, Inc. At Omexa, we are at the forefront of biologics innovation, dedicated to producing high-quality alternatives to brand-name biologics and stem cell therapies. Our mission is to enhance patient access to vital treatments while ensuring safety, efficacy, and affordability. Harnessing advanced technologies and rigorous scientific methodologies, we bridge the future of healthcare with today's needs. Discover the Omexa difference, where precision meets passion in biosimilar manufacturing. Welcome to a healthier tomorrow.
Company Details
- Employees
- 6
- Founded
- -
- Address
- Los Angeles, California, Us
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.omexa.bio
- Keywords
- Biosimilar, Biologics, Skincare.
- HQ
- Los Angeles, California
Omexa Questions
Omexa's website is http://www.omexa.bio
Omexa's LinkedIn profile is https://www.linkedin.com/company/omexa
Omexa has
6 employees.
View email and phone details for 6
employees at Omexa.
Omexa's industry is
Pharmaceutical Manufacturing
Omexa's top competitors are
Prp Ventures,
Avesthagen Limited,
Plantagenix,
Krinsta Ventures,
Jacobs,
Allozymes,
String Bio Private Limited,
Appasamy Associates,
Omexa Formulary Pvt Ltd,
Stella Polaris®.
Omexa's categories are Pharmaceutical Manufacturing
Omexa's founding year is 2023
